{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:44:21Z","timestamp":1783338261674,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cca.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:37:48Z","timestamp":1557743868000},"page":"406-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Simultaneous quantification of 48 plasma amino acids by liquid chromatography-tandem mass spectrometry to investigate urea cycle disorders"],"prefix":"10.1016","volume":"495","author":[{"given":"Min-Zhi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Na","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.05.011_bb0005","series-title":"Physician\u2019s Guide to the Laboratory Diagnosis of Metabolic Diseases","first-page":"261","article-title":"Inherited Hyperammonemias","author":"Bachmann","year":"2003"},{"key":"10.1016\/j.cca.2019.05.011_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.05.011_bb0015","first-page":"428","article-title":"Clinical diagnosis and treatment of three cases with hyperornithinemia- hyperammonemia-homocitrullinuria syndrome","volume":"55","author":"Guan","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.cca.2019.05.011_bb0020","first-page":"676","article-title":"Mutational analysis of ASS1, ASL and SLC25A13 genes in six Chinese patients with citrullinemia","volume":"35","author":"Lin","year":"2017","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.cca.2019.05.011_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.13004","article-title":"Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency","volume":"92","author":"Shao","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cca.2019.05.011_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"H\u00e4berle","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cca.2019.05.011_bb0035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2019.05.011_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-4347(93)80136-R","article-title":"Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography","volume":"613","author":"M\u00f8ller","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2019.05.011_bb0045","first-page":"97","article-title":"Amino acid profiles in patients with urea cycle disorders at admission to hospital due to metabolic decompensation","volume":"6","author":"Rodney","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.cca.2019.05.011_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1442-200X.2006.02181.x","article-title":"Late-onset ornithine transcarbamylase deficiency in male patients: Prognostic factors and characteristics of plasma amino acid profile","volume":"48","author":"Harada","year":"2006","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.cca.2019.05.011_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10545-008-0903-0","article-title":"Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency","volume":"31","author":"Scholl-B\u00fcrgi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2019.05.011_bb0060","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1203\/01.pdr.0000238301.25938.f5","article-title":"Clinical and functional characterization of a human ornt1 mutation (T32R) in the hyperornithinemia-hyperammonemia- homocitrullinuria (HHH) syndrome","volume":"60","author":"Camacho","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2019.05.011_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1203\/00006450-199509000-00009","article-title":"Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry","volume":"38","author":"Rashed","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2019.05.011_bb0070","series-title":"Amino Acid Analysis","first-page":"55","article-title":"Amino Acid Analysis by Hydrophilic interaction chromatography coupled with isotope dilution mass spectrometry","author":"Kato","year":"2012"},{"key":"10.1016\/j.cca.2019.05.011_bb0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/rcm.1957","article-title":"Ion-pairing reversed-phase liquid chromatography\/electrospray ionization mass spectrometric analysis of 76 underivatized amino acids of biological interest: A new tool for the diagnosis of inherited disorders of amino acid metabolism","volume":"19","author":"Piraud","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.cca.2019.05.011_bb0080","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/ac0111917","article-title":"Validated quantitation of underivatized amino acids in human blood samples by volatile ion-pair reversed-phase liquid chromatography coupled to isotope dilution tandem mass spectrometry","volume":"74","author":"Qu","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpba.2015.06.001","article-title":"Amino acid analysis using chromatography\u2013mass spectrometry: An inter platform comparison study","volume":"114","author":"Krumpochova","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2019.05.011_bb0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00726-014-1682-6","article-title":"Analysis of 26 amino acids in human plasma by HPLC using AQC as derivatizing agent and its application in metabolic laboratory","volume":"46","author":"Sharma","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.cca.2019.05.011_bb0095","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1021\/ac0600510","article-title":"Enhancement of amino acid detection and quantification by electrospray ionization mass spectrometry","volume":"78","author":"Yang","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0100","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/ac900470w","article-title":"Multifunctional and highly sensitive precolumn reagents for amino acids in liquid chromatography\/tandem mass spectrometry","volume":"81","author":"Shimbo","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0105","series-title":"Amino Acid Analysis: Methods and Protocols","first-page":"165","article-title":"Amino acid analysis in physiological samples by GC\u2013MS with propyl chloroformate derivatization and iTRAQ\u2013LC\u2013MS\/MS","author":"Dettmer","year":"2012"},{"key":"10.1016\/j.cca.2019.05.011_bb0110","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1039\/C4AN01672F","article-title":"A novel amino acid analysis method using derivatization of multiple functional groups followed by liquid chromatography\/tandem mass spectrometry","volume":"140","author":"Sakaguchi","year":"2015","journal-title":"Analyst."},{"key":"10.1016\/j.cca.2019.05.011_bb0115","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jchromb.2009.05.019","article-title":"Urinary amino acid analysis: A comparison of ITRAQ\u00ae\u2013LC\u2013MS\/MS, GC\u2013MS, and amino acid analyzer","volume":"877","author":"H.Kaspar, K. Dettmer, Q. Chan, S. Daniels, S. Nimkar, M. Daviglus","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2019.05.011_bb0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/JPEM.2011.270","article-title":"Establishment of reference range of plasma amino acids for younger Chinese children by reverse phase HPLC","volume":"24","author":"Yi","year":"2011","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.05.011_bb0125","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Method Validation, http:\/\/ www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances (2013)."},{"key":"10.1016\/j.cca.2019.05.011_bb0130","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1373\/clinchem.2007.099226","article-title":"Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization\u2013 mass spectrometry","volume":"54","author":"Minkler","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2016.01.026","article-title":"The effects of pre-analysis sample handling on human plasma amino acid concentrations","volume":"455","author":"Takehana","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.05.011_bb0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acs.jproteome.7b00518","article-title":"Long-term stability of human plasma metabolites during storage at -80 \u00b0C","volume":"17","author":"Haid","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2019.05.011_bb0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/clinchem\/44.4.825","article-title":"Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine","volume":"44","author":"Pastore","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0150","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00216-012-5727-y","article-title":"Study of disulfide reduction and alkyl chloroformate derivatization of plasma sulfur amino acids using gas chromatography\u2013mass spectrometry","volume":"402","author":"\u0160vagera","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0155","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1373\/clinchem.2007.100438","article-title":"Importance of chemical reduction in plasma and serum homocysteine analysis","volume":"54","author":"Ueland","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0160","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/clinchem\/43.12.2397","article-title":"Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population","volume":"43","author":"Lepage","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0165","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/clinchem\/39.9.1764","article-title":"Total homocysteine in plasma or serum: methods and clinical applications","volume":"39","author":"Ueland","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0170","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2011.163188","article-title":"Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis","volume":"57","author":"Jaisson","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.05.011_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2014.01.032","article-title":"Molecular genetics of citrullinemia types I and II","volume":"431","author":"Woo","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.05.011_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10545-017-0132-5","article-title":"Biochemical markers and neuropsychological functioning in distal urea cycle disorders","volume":"41","author":"Waisbren","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2019.05.011_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/6815","article-title":"SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance","volume":"21","author":"Borsani","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2019.05.011_bb0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/9658","article-title":"Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter","volume":"22","author":"Camacho","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2019.05.011_bb0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.spen.2008.05.007","article-title":"Neurologic damage and neurocognitive dysfunction in urea cycle disorders","volume":"15","author":"Enns","year":"2008","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.cca.2019.05.011_bb0200","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.cca.2019.05.011_bb0205","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ymgme.2004.04.010","article-title":"Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders","volume":"82","author":"Peduto","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.05.011_bb0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/A:1022889400302","article-title":"Plasma pipecolic acid is frequently elevated in non-peroxisomal disease","volume":"25","author":"Baas","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2019.05.011_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.cca.2019.05.011_bb0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2009.07.021","article-title":"Experimental evidence that ornithine and homocitrulline disrupt energy metabolism in brain of young rats","volume":"1291","author":"Viegas","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.cca.2019.05.011_bb0225","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s11064-016-1933-x","article-title":"Ornithine and homocitrulline impair mitochondrial function, decrease antioxidant defenses and induce cell death in menadione-stressed rat cortical astrocytes: potential mechanisms of neurological dysfunction in HHH syndrome","volume":"41","author":"Zanatta","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cca.2019.05.011_bb0230","series-title":"Physician\u2019s Guide to the Laboratory Diagnosis of Metabolic Diseases","first-page":"243","article-title":"Disorder of sulfur amino acids","author":"Skovby","year":"2003"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119318625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119318625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:50:18Z","timestamp":1757861418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119318625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":46,"alternative-id":["S0009898119318625"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.05.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of 48 plasma amino acids by liquid chromatography-tandem mass spectrometry to investigate urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}